HCG to Launch 2 Advanced Comprehensive Cancer Care Centers in Bengaluru

The new centers will offer comprehensive cancer care services including high-precision diagnosis, and personalized treatment plans, among others, all available at the same location.

Leading cancer care chain, Healthcare Global Enterprises (HCG) to soon launch two comprehensive cancer care centers in India’s Silicon Valley.

The centers in Whitefield and North Bengaluru are set to start operations in early 2025.

The new cancer facilities will offer comprehensive cancer care services including high-precision diagnosis, personalized treatment plans, among others, all available at the same location.

This expansion aims to bring advanced cancer treatment to these populous areas of the city. The centers will be the third and fourth HCG facilities in Bengaluru.

Expressing thoughts, Raj Gore, CEO, HCG, said, "We are focused on expanding our reach and taking HCG’s comprehensive & quality cancer care services closer to patients in and around Bengaluru. As a leading healthcare provider dedicated to excellence, we remain firm in our commitment to investing in new infrastructure, advanced treatments, and cutting-edge technology.”

Currently, HCG operates 21 comprehensive cancer centers and 24 hospitals across India and Africa, along with seven day-care centers.

HCG’s Bengaluru Expansion

The new HCG facilities in Whitefield and North Bengaluru will offer integrated and holistic cancer care, with a total of 125 beds.

These additions to the HCG chain of cancer care hospitals in the city are strategically located, similar to HCG’s flagship Centre of Excellence at KR Road and Double Road, which has a total of 300 beds.

In addition to these four modern centers, HCG operates three daycare centers in the residential neighborhoods of Kalyan Nagar, Malleshwaram, and Banashankari.

Further, HCG plans to introduce two new daycare centers to the city network, aiming to make cancer care more accessible to patients requiring repeated treatments such as chemotherapy by reducing travel time.

Reportedly, the North Bengaluru facility will be equipped with an MR LINAC radiation system.

This technology, which combines magnetic resonance imaging (MRI) with a linear accelerator (LINAC), aims to improve clinical outcomes, minimize side effects, and shorten the treatment period.

Talking about the expansion plan, Dr B S Ajaikumar, executive chairman, HCG, said, “Our new advanced centres at Whitefield and North Bengaluru are pivotal to our aim of extending our network to the local community sustainably, ensuring high-quality cancer care is accessible to all. With Bengaluru being HCG's home ground, this expansion not only reflects our deep-rooted connection to the city but also our commitment to enhancing the healthcare landscape for the benefit of the local community.”

Recently, HCG had set up a new healthcare equity fund, Inviga. The fund also made its maiden investment in Mynvax, a biotechnology company.

Mynvax, known for its innovative solutions in the healthcare domain, is expected to benefit significantly from this investment.

According to the cancer care chain, this healthcare fund aims to support the Indian healthcare entrepreneur ecosystem, foster clinical excellence, focus tenaciously on the quality of outcomes, drive deep social impact, and help build businesses on sustainable vectors.